A study of nearly 100,000 US residents found thousands of pharmacogene variants that may affect drug efficacy and safety. Funding cuts could limit the All of Us program. Scientists analyzed 16 pharmacogenes — genes associated with responses to medications. Every study participant had at least one variant in these genes. About one in four participants was taking medications whose effectiveness or safety may be affected by such genetic characteristics.